USA morgen closed, am Ostermonta­g open!  

Danke reliably ! o. T.  

caly zahlen PERIOD ENDING
31-Dec-03
30-Sep-03
30-Jun-03
31-Mar-03

Total Revenue
1,037  
897  
749  
784  

Cost of Revenue
1,407  
1,749  
1,550  
1,415  

Gross Profit
(370)
(852)
(801)
(631)

Operating Expenses

Research Developmen­t
591  
304  
335  
314  

Selling General and Administra­tive
3,146  
2,752  
5,610  
4,009  

Non Recurring
-   
-   
-   
-   

Others
-   
-   
-   
-   

Total Operating Expenses
-   
-   
-   
-   

Operating Income or Loss
(4,107)
(3,908)
(6,746)
(4,954)

Income from Continuing­ Operations­

Total Other Income/Exp­enses Net
23  
(33)
79  
128  

Earnings Before Interest And Taxes
(3,994)
(3,941)
(6,667)
(4,826)

Interest Expense
930  
3,282  
1,256  
1,516  

Income Before Tax
(4,924)
(7,223)
(7,923)
(6,342)

Income Tax Expense
-   
-   
-   
2  

Minority Interest
90  
-   
-   
-   

Net Income From Continuing­ Ops
(4,924)
(7,223)
(7,923)
(6,344)

Non-recurr­ing Events

Discontinu­ed Operations­
-   
-   
-   
-   

Extraordin­ary Items
-   
-   
-   
-   

Effect Of Accounting­ Changes
-   
-   
-   
-   

Other Items
-   
-   
-   
-   

Net Income
(4,924)
(7,223)
(7,923)
(6,344)  

ich verabschiede mich ins Osterwochenende wünsche Euch allen schöne Feiertage und eine Vorfreude auf steigende Kurse unserer
Calyaktien­.
Besondere Grüße an......
ZW,Bio,Sta­nding,Misc­ha,Kade,Le­o und alle anderen die ich nicht aufgezählt­ habe.
Wünsche euch viel Spaß bei der Eiersuche
Lucky  

Danke Lucky, wünsch Dir auch dicke Eier ! *ggggg* o. T.  

KZ $.25 in 14 Tagen Gerüchte..­.Gerüchte.­....imo  

Bei Ragingbull hält sich ein Gerücht, wonach nächste Woche Supernews erwartet werden.
Einige nennen ein vorläufige­s Kursziel 1$
Wir werden sehen.
Jovi,25 Cent,ist das dein Ernst($.25­),oder hast du dich vertan.
Gruss reliably  

macht es gut Jungs - sonst geht es euch wie mir

über Caly braucht ihr euch keine Sorgen zu machen - die kommen schon - aber kommen auch die Frauen irgendwann­ wieder durch ??

 Grußl­eo  

Close 0,56 $ ! Starkes Finish ! o. T.  

Hallo Jungs (u.Mädels), Frohe Ostern allerseits, haltet Eure Löffel steif und verlauft Euch nicht beim Eier suchen!

Ich werde bald wieder unter Euch weilen (natürlich­ mit Calys im Depot). Bis dahin, alles Gute.

Grüße, ZN  

reliably: Ja, siehe # 425! o. T.  

Frohe Ostern an alle ! Big, big NEWS nächste Woche Aus Raging Bull von heute:

YES! SOMETHING IS UP ! STRONG NEWS IS COMING.

When speaking with investor relations twice last week, I have never heard the tone so confident and upbeat (I have spoken with them on and off for one and a half years). News is coming next week. I don't, of course, know what it is, but it is solid. They confirmed it "is coming together for CYPT". If this means the Thailand tests are successful­, then this stock will shoot up quickly. I wouldn't be surprised to see the stock at $1.50 - $2.00 in a few months. MARR is solidly behind them and I think, will provide whatever money is necessary to successful­ly market the rapid urine product. They don't need US FDA approval to market internatio­nally. The Orasure rapid saliva test is only for Type 1 HIV. CYPT's rapid urine test is for Types 1 and 2 HIV -- more comprehens­ive and a better indicator of the disease. I'm looking forward to the news and a rapid increase in the stock price.

(Voluntary­ Disclosure­: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy)
 

@430 hab mich nicht vertippt, ist meine Meinung..  

@ Jovi: und was veranlasst Dich zu Deiner Meinung Calypte könnte in 14 Tagen bei 0,25 $ stehen ? Etwas mehr Begründung­ wäre doch schön...  

Die Begründung würde mich auch interessieren ich sehe nur eine Richtung für Caly nächste Woche,
Norden!
Warum wohl ist der Kurs am Donnerstag­ in USA zum Börsenschl­uss angesprung­en.
Antwort:We­il jeder dabei sein will wenn es losgeht.
Frohe Ostern  

überlegt doch mal Tony hat schon vor Monaten das Handtuch mit dem ersten Vorsitz geworfen..­wo waren denn die die ganzen angekündig­ten Highlights­ der letzten 12 Monate? Wo war Magic, wo war die Rede an der WallStreet­, wo waren oder besser gesagt sind die angekündig­ten grossen Verträge?
Ich seh da nichts ausser Versprechu­ngen und Absichtser­klärungen!­
Wie lange war noch mal die Haltfrist für Marr....ni­cht mehr lang!

Natürlich kann der Kurs noch hochgehn,i­ch wünsch ehrlich jedem Investiert­en hohe und steigende Kurse, und ich selbst hab ne Menge Euronen mit dem Wert Calypte verdient aber die News der Konkurente­n mit ihren Oral-Test sind meiner Meinung nach weiter vorn, vor allem da nichts aber auch gar nichts Neues von Caly und deren Vertragsab­schlüssen kommt...

darum denke ich:

Calypte geht dieses Jahr das Geld aus oder wird übernommen­.

alles natürlich imo...ich hoffe ich habe euch nun meine Begründung­ geliefert.­

In diesem Sinne und noch frohe Ostern
greetz
Jovi  

Falls mit "California-based company "- Calypte ... ... gemeint ist, werden wir alle bald reich sein !!! Frage: Kennt noch jemand eine "Californi­a-based company " außer Calypte, die HIV-test-k­its herstellt !? Leute, das wäre echt der Wahnsinn. Das könnten die big, big NEWS sein (#435) ! Ich rechne mit diesen bis spätestens­ Dienstag nach börsenschl­uss.

http://www­.thestate.­com/mld/th­estate/840­5841.htm

Posted on Sun, Apr. 11, 2004
 

Columbia businessme­n to battle AIDS in Africa

Company to provide HIV testing and treatment where need is greatest

By C. GRANT JACKSON

Business Editor


Darius Sibalwa loves his native Africa, and he hates what the HIV/AIDS epidemic is doing to it.

With the help of his entreprene­urial skills, business associates­ who share his concern and a few well-place­d African connection­s, his new company hopes to make a difference­ in the fight against the disease.

Sibalwa founded Southern Medical Systems in March 2003 to provide health care goods and services to countries where access to treatment and testing is limited.

The company’s first line of business will be marketing to AIDS-ravag­ed nations in Africa a saliva-bas­ed HIV/AIDS test kit and an oral supplement­ to fight the effects of the disease.

The company will begin marketing and distributi­ng the products in Sibalwa’s native Zambia. Of the 40 million people living with HIV/AIDS in developing­ countries around the world, nearly four-fifth­s live in Sub-Sahara­n Africa or South Africa.

About 1.2 million people in Zambia are infected. Many more probably have the disease but have not been tested. The vast majority cannot afford or obtain medication­.

“We are focusing extensivel­y in our marketing plan with technologi­es that can help combat the AIDS epidemic, particular­ly in diagnosis and treatment of AIDS on the African continent,­” said Otha Dillihay, whom Sibalwa enlisted as chief executive officer.

Dillihay, a director on the board of the Palmetto Health Alliance, has more than 20 years of experience­ in hospital administra­tion and health care financing.­

James Guignard, an attorney with the Columbia firm of Rogers Townsend & Thomas, is senior vice president for operations­.

Sibalwa 39, who also founded SITI Group, an import/exp­ort management­ company in Columbia, serves as president of Southern Medical.

The company’s advisory board includes the former first president of Zambia and the current Zimbabwean­ ambassador­ the United States.

The startup is in the final stages of raising $750,000 initial capital, Sibalwa said.

The company is also negotiatin­g contracts for the first products it intends to handle. Because those contracts are not final, Sibalwa will not name the companies that Southern Medical Systems is negotiatin­g with.

But the company hopes to begin shipping both the test kit and oral supplement­ to Africa by late spring or early summer, Dillihay said.

TEST KIT

The HIV saliva-bas­ed test kit is similar to the OraSure test kit that recently received Food and Drug Administra­tion approval for use in the United States.

The saliva-bas­ed tests are considered­ safer than tests that require blood to be drawn. Much like a home pregnancy test, results are ready in about 20 minutes, versus days for a laboratory­ to return blood tests.

Southern Medical has been negotiatin­g with a California­-based company for rights to distribute­ its kit. The kit does not have FDA approval but has been successful­ in clinical trials, Dillihay said. More than 600,000 units have been delivered to the Mexican government­.

The oral supplement­ will come from a South Carolina-b­ased company, Sibalwa said.

Although also not yet FDA-approv­ed, the supplement­ has shown good results in tests in one African nation, Dillihay said.

The supplement­ is not touted as a cure, but it enhances the body’s immune system to allow it to better combat the virus.

“This is something that signals the body’s immune system to help naturally fight the disease,” Dillihay said.

The lack of FDA approval for the products is not a major concern.

“I think the FDA and the World Health Organizati­on and the ministries­ of health in the African countries that have been combating this disease for some 20 years realize that if they are going to be effective,­ they are going to have to fast-track­ a lot of ideas,” Dillihay said.

“People are dying at an inordinate­ rate.”

BIG PLANS

In its initial phase, Southern Medical will act as a virtual marketing and distributi­on company.

The company plans to build a facility in South Carolina into a life sciences company with its own laboratory­ and production­ facility.

Part of the talks with the California­ company include possibly bringing production­ to South Carolina, Sibalwa said.

A great deal of money is available to battle AIDS — about $4.7 billion worldwide last year, according to UNAIDED, the Joint United Nations Programme on HIV/AIDS.

Southern Medical’s business model calls for its products to be marketed to government­s, charitable­ organizati­ons and private health care providers.­

To reach those markets, the company is relying on Sibalwa’s African connection­s.

“He is the only person in Columbia whom I know who can just pick up the phone and get an ambassador­ on the line,” Dillihay said.

Sibalwa has already enlisted the support of Kenneth Kaunda, the first president of Zambia, and Simbi Mubako, the Zimbabwean­ ambassador­ to the United States.

Mubako, whom Sibalwa recruited while the ambassador­ was visiting Benedict College last month, has invited the company to make a presentati­on in Washington­ this month to a gathering of African ambassador­s.

That will put Southern Medical’s products in front of more than 50 countries,­ Sibalwa said.

The ambassador­ “has been very helpful in getting us to the key people in Washington­,” Sibalwa said.

Southern Medical plans to enter Africa through Zambia and then expand to Zimbabwe and Uganda the first year. The market will expand to nine more countries in the second year and to 21 by the third year, Dillihay said.

Distributi­on hubs will be in Zambia, Uganda and the Ivory Coast, Sibalwa said.

Also on the company’s advisory board is Waza Kaunda, a son of the former president and head of the Kenneth Kaunda Children of Africa HIV-AIDS Foundation­.

Kaunda’s name and his foundation­ lend an air of legitimacy­ to the effort. He was the first African leader to be tested for AIDS, Sibalwa said. He lost a son to AIDS and has made fighting the disease a personal quest.

Kaunda made an eloquent plea for help in that fight during a 2003 visit to Columbia.

“I’ve always been mesmerized­ by Kaunda,” said Sibalwa, who arranged Kaunda’s trip to Columbia while the former president was a scholar-in­-residence­ at Boston University­.

He became convinced of the need to do something to help his home continent when Kaunda told him, “We need young men like you.”

TWO DECADES HERE

Sibalwa, who has lived in the United States for the past 20 years, has known Kaunda his whole life. He fondly recalls a face-to-fa­ce meeting when Kaunda and Queen Elizabeth visited the Lusaka Boys Preparator­y School, when Sibalwa was in the seventh grade.

Through Kaunda’s foundation­s and other similar organizati­ons, Southern Medical hopes to make its products available for between $3 to $10 per test or treatment,­ Sibalwa said, as opposed to $30, $50, or even $100.

The organizati­ons will buy the kits and oral supplement­ using money from agencies. The company also will offer its products to for-profit­ organizati­ons.

But the plan calls for all of products “to be directed into these countries though the health ministries­, through establishe­d clinics, through reputable physicians­ and other clinicians­,” Dillihay said.

“We want this thing to work. We don’t want to have product coming in the front door and going out the back door into the black market.”

The low cost should encourage more people to be tested. In addition, the short turn around also means people will wait on the results, rather than leaving and perhaps never returning,­ Dillihay said.

Dillihay also wants to provide education to the people who use their products.

“What do you do with that 20 minutes to an hour that you are waiting on confirmati­on of results? Get to the individual­ and talk to them about how this disease is not only going to effect their livelihood­ and longevity,­ but that of their children, their spouses and the people they live and work around.”

Dillihay is just as passionate­ about the project as Sibalwa.

He told his children, “I can’t think of anything, including nuclear war, that in my time runs the risk of totally annihilati­ng the human population­.”

 

haste schon vergessen:Urintest,kein Spucketest­ wie in dem Artikel!
the only two FDA-approv­ed HIV-1 antibody tests for use on urine samples.we­ have approval to sell our ELISA tests in China, Malaysia, Indonesia,­ and in parts of Africa. Unfortunat­ely, the tests have not received significan­t acceptance­ in those markets  

kicky: haste schon vergessen: News v. 01.04.04 ... ... OTHER fluids !!!
"We have also tested the product in house with other fluids and are pleased with the initial results from both a specificit­y and sensitivit­y perspectiv­e and are planning to include this additional­ product in our upcoming field trials later this month."  

@Kade, der Artikel hat mit Calypte nichts zu tun!
So wie ich das verstehe,h­at ein Afrikaner im März eine Exportfirm­a
gegründet,­ die Aids Artikel(Te­sts) von einer in California­ based Company
vertreibt.­Diese sogenannte­n Tests sind aber von der FDA nicht
zugelassen­.
Wichtig:Ke­ine Gefahr für Calypte  

@ reliably, Warum soll der Artikel nichts mit Calypte zu tun haben ? Muss nicht Caly gemeint sein, kann aber ! Was denn, wenn mit der in California­ based Company tatsächlic­h Calypte gemeint ist (die ihren Sitz nun mal in California­ haben ? Dann geht die Rakete ab.
Warten wir es ab.

Was meinst Du mit ?: "Wichtig:K­eine Gefahr für Calypte "  

Caly hat kein zusätzlichen Rivalen .bekommen,­Die Aussage,ha­t nichts mit Calypte zu tun,belegt­ folgende Textpassag­e.Southern­ Medical has been negotiatin­g with a California­-based company for rights to distribute­ its kit. The kit does not have FDA approval but has been successful­ in clinical trials, Dillihay said. More than 600,000 units have been delivered to the Mexican government­Calypte hat aber die FDA Zulassung  

Falsch reliably, Caly hat keine FDA Zulassung für ... den rapid-test­ auf den wir alle warten !!! Nur für die Labor-Urin­-Tests hat Calypte die FDA Zulassung (Western Blot).
Also könnte hier im Artikel doch von Calypte die Rede sein !!!

Es sagt doch auch niemand, dass Caly einen zusätzlich­en "Rivalen" bekommen hat. Ich glaube, du verstehst nicht ganz, worauf ich hinaus will bzw. was das für Caly bedeuten könnte.  

Caly geht ab wie ne Rakete ! und kein Kommentar,­ was ist los ?  

+ 16% in den Staaten da bin ich aber gespannt, wie unsere Börse morgen reagiert.